Chronic Myeloid Leukemia Treatments

32 ta ish

1. Optimizing ibrutinib bioavailability: Formulation and assessment of hydroxypropyl-β-cyclodextrin-based nanosponge delivery systems

   Sunitha Sampathi, Nitiraj Kulkarni, D. V. R. N. Bhikshapathi +4

   MaqolaOAOchiq kirishChronic Lymphocytic Leukemia ResearchCurrent Research in Pharmacology and Drug Discovery20253 iqtibos

   ABIABI:AkademIndex/2025.article.000278

2. An odyssey of monoclonal gammopathies: focusing on precursors and the progression from MGUS and SMM to multiple Myeloma, with a brief overview of novel therapeutic strategies

   Xin Xin, Chunhui Fan, Ran Sheng +7

   MaqolaOAOchiq kirishMultiple Myeloma Research and TreatmentsClinical and Experimental Medicine20261 iqtibos

   ABIABI:AkademIndex/2026.article.000299

3. Placental transfer of tyrosine kinase inhibitors used for chronic myeloid leukemia treatment

   Ekaterina Chelysheva, Anna Turkina, Evgeniya Polushkina +9

   MaqolaChronic Myeloid Leukemia TreatmentsLeukemia & lymphoma/Leukemia and lymphoma20171 iqtibos

   ABIABI:AkademIndex/2026.other.108174

4. Fostamatinib boosts QOL in RA

   MaqolaChronic Myeloid Leukemia TreatmentsPharmacoEconomics & Outcomes News20110 iqtibos

   ABIABI:AkademIndex/2011.article.000596

5. 1-Methoxyficifolinol

   Shakhnoza S. Azimova, Валентина И. Виноградова

   BobChronic Myeloid Leukemia Treatments20120 iqtibos

   ABIABI:AkademIndex/2012.chapter.002509

6. Ajmaline

   Shakhnoza S. Azimova, Marat S. Yunusov

   BobChronic Myeloid Leukemia Treatments20120 iqtibos

   ABIABI:AkademIndex/2012.chapter.003051

7. Laudanidine

   Shakhnoza S. Azimova, Marat S. Yunusov

   BobFungal Plant Pathogen Control20120 iqtibos

   ABIABI:AkademIndex/2012.chapter.006348

8. Chronic Myeloid Leukemia Diagnosed during Pregnancy: Therapy, Outcomes and Follow-up

   Ekaterina Chelysheva, Elisabetta Abruzzese, Delphine Réa +9

   MaqolaChronic Myeloid Leukemia TreatmentsBlood20180 iqtibos

   ABIABI:AkademIndex/2018.article.000303

9. Pregnancy Management in CML Patients: To Treat or Not to Treat? Report of 224 Outcomes of the European Leukemia Net (ELN) Database

   Elisabetta Abruzzese, Anna Turkina, Jane F. Apperley +21

   MaqolaChronic Myeloid Leukemia TreatmentsBlood20190 iqtibos

   ABIABI:AkademIndex/2019.article.000226

10. PF666 LOW JAK2 V617F ALLELE BURDEN PHI‐NEGATIVE CHRONIC MYELOPROLIFERATIVE NEOPLASMS MAY ASSOCIATE WITH ADDITIONAL CALR OR MPL MUTATIONS

    Tatiana Makarik, Akmaljon Odilov, А О Абдуллаев +7

    MaqolaOAOchiq kirishMyeloproliferative Neoplasms: Diagnosis and TreatmentHemaSphere20190 iqtibos

    ABIABI:AkademIndex/2019.article.001242

11. Clinical observation of chronic myeloid leukemia with variant translocation and supplementary rearrangement t(1;8)(q23;q24.3)

    Yu. Yu. Assesorova, L. K. Mustafina, Saniyat Yusupova +1

    MaqolaOAOchiq kirishChronic Myeloid Leukemia TreatmentsRussian journal of hematology and transfusiology20210 iqtibos

    ABIABI:AkademIndex/2021.article.009425

12. Aberrant Hydroxymethylation In Promoter Cpg Regions of Genes Related to the Cell Cycle and Apoptosis Characterizes Advanced Chronic Myeloid Leukemia Disease, Poor Imatinib Respondents And Poor Survival.

    Sameer Ahmad Guru, Mamta P. Sumi, Rashid Mir +3

    PreprintChronic Myeloid Leukemia TreatmentsResearch Square20210 iqtibos

    ABIABI:AkademIndex/2021.preprint.000053

13. Chronic Myeloid Leukemia Diagnosed during Pregnancy: How to Manage? Description of 86 Cases from ELN International Registry

    Ekaterina Chelysheva, Anna Turkina, Jane F. Apperley +18

    MaqolaChronic Myeloid Leukemia TreatmentsBlood20220 iqtibos

    ABIABI:AkademIndex/2022.article.001448

14. Use of a New Structure of Fluorescent-Labeled DNA Oligonucleotides to Reveal Mutation JAK2 V617F During Development of Leukemia

    A. A. Makhnev, A. B. Baimirzaev, Kh. Z. Nasriddinov +2

    MaqolaMyeloproliferative Neoplasms: Diagnosis and TreatmentChemistry of Natural Compounds20220 iqtibos

    ABIABI:AkademIndex/2022.article.008641

15. CML-491 Case Report of Variant Translocations and Atypical BCR::ABL Transcripts in CML Management

    Bekhzodkhon Bakhodirov, Kamoliddin Olimjonov, Элдор Исхаков +7

    MaqolaChronic Myeloid Leukemia TreatmentsClinical Lymphoma Myeloma & Leukemia20230 iqtibos

    ABIABI:AkademIndex/2023.article.003956

16. POSTER: CML-491 Case Report of Variant Translocations and Atypical BCR::ABL Transcripts in CML Management

    Bekhzodkhon Bakhodirov, Kamoliddin Olimjonov, Элдор Исхаков +7

    MaqolaOAOchiq kirishChronic Myeloid Leukemia TreatmentsClinical Lymphoma Myeloma & Leukemia20230 iqtibos

    ABIABI:AkademIndex/2023.article.010137

17. POSTER: CML-449 JAK2-Unmutated Erythrocytosis in Chronic Phase Myeloid Leukemia (CP-CML) During Tyrosine Kinase Inhibitor (TKI) Treatment

    Olga Kulemina, Julia Yakovleva, Natalia Lazorko +6

    MaqolaChronic Myeloid Leukemia TreatmentsClinical Lymphoma Myeloma & Leukemia20230 iqtibos

    ABIABI:AkademIndex/2023.article.010138

18. POSTER: CML-319 Molecular Response of ≤10% BCR::ABL1IS Is Predictive of Positive Outcomes in Patients With Treatment-Resistant Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Treated With Ponatinib From the Phase 2 OPTIC Trial

    Jane F. Apperley, Jörge E. Cortes, Elias Jabbour +21

    MaqolaOAOchiq kirishChronic Myeloid Leukemia TreatmentsClinical Lymphoma Myeloma & Leukemia20230 iqtibos

    ABIABI:AkademIndex/2023.article.010140

19. POSTER: ALL-296 Results of Treatment of Children With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia With Low-dose Chemotherapy Without Bone Marrow Transplantation in Uzbekistan

    Rahmatulla Hadiyev, Ibragimova Sapura

    MaqolaOAOchiq kirishChronic Myeloid Leukemia TreatmentsClinical Lymphoma Myeloma & Leukemia20230 iqtibos

    ABIABI:AkademIndex/2023.article.010149

20. CML-640 Case Report of Metachronous Ph+ and Ph Myeloproliferative Neoplasms

    Kamoliddin Olimjonov, Anna Pirkhalo, Elizaveta Efremova +7

    MaqolaMyeloproliferative Neoplasms: Diagnosis and TreatmentClinical Lymphoma Myeloma & Leukemia20230 iqtibos

    ABIABI:AkademIndex/2023.article.010151

21. Chronic myeloid leukemia diagnosed in pregnancy: management and outcome of 87 patients reported to the European LeukemiaNet international registry

    Ekaterina Chelysheva, Jane F. Apperley, Anna Turkina +16

    MaqolaOAOchiq kirishChronic Myeloid Leukemia TreatmentsLeukemia20240 iqtibos

    ABIABI:AkademIndex/2024.article.000276

22. Correction: Chronic myeloid leukemia diagnosed in pregnancy: management and outcome of 87 patients reported to the European LeukemiaNet international registry

    Ekaterina Chelysheva, Jane F. Apperley, Anna Turkina +16

    BoshqaOAOchiq kirishChronic Myeloid Leukemia TreatmentsLeukemia20240 iqtibos

    ABIABI:AkademIndex/2024.other.000008

23. AML-095: Loss of Sex Chromosome in Acute Myeloid Leukemia

    Doskhan Orazkhanov, M Islamov, Zulkhumor Yunusova +1

    MaqolaAcute Myeloid Leukemia ResearchClinical Lymphoma Myeloma & Leukemia20250 iqtibos

    ABIABI:AkademIndex/2025.article.003181

24. POSTER: AML-095 Loss of Sex Chromosome in Acute Myeloid Leukemia

    Doskhan Orazkhanov, M Islamov, Zulkhumor Yunusova +1

    MaqolaChronic Myeloid Leukemia TreatmentsClinical Lymphoma Myeloma & Leukemia20250 iqtibos

    ABIABI:AkademIndex/2025.article.008074

25. THE SIGNIFICANCE OF DRIVER GENE MUTATIONS JAK2, CALR, AND MPL IN CHRONIC MYELOPROLIFERATIVE DISEASES

    Beknur Bobir ugli Giyosov, Kodirjon Tukhtaboevich Boboev, Feruz Asatullaevich Daminov

    MaqolaOAOchiq kirishMyeloproliferative Neoplasms: Diagnosis and TreatmentZenodo (CERN European Organization for Nuclear Research)20260 iqtibos

    ABIABI:AkademIndex/2026.article.000932